3.87
Avita Medical Inc stock is traded at $3.87, with a volume of 378.60K.
It is up +5.45% in the last 24 hours and down -24.27% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$3.67
Open:
$3.67
24h Volume:
378.60K
Relative Volume:
0.60
Market Cap:
$103.02M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-2.7643
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
-2.52%
1M Performance:
-24.27%
6M Performance:
-60.06%
1Y Performance:
-61.68%
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
RCEL
Avita Medical Inc
|
3.87 | 99.16M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
How AVITA Medical Inc. stock performs during Fed tightening cyclesGlobal Markets & Detailed Earnings Play Alerts - newser.com
Is AVITA Medical Inc. stock attractive for ETFsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
How to escape a deep drawdown in AVITA Medical Inc.Short Setup & Low Drawdown Momentum Ideas - newser.com
How analysts rate AVITA Medical Inc. stock todayQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Using AI based signals to follow AVITA Medical Inc.2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Will AVITA Medical Inc. stock benefit from commodity prices2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonTrade Volume Summary & Safe Capital Investment Plans - newser.com
AVITA Medical, Inc. (RCEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why AVITA Medical Inc. stock remains a top recommendationJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceEntry Point & Community Trade Idea Sharing Platform - newser.com
Published on: 2025-11-01 12:29:56 - newser.com
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Historical volatility pattern of AVITA Medical Inc. visualizedQuarterly Profit Report & Real-Time Volume Analysis Alerts - newser.com
Can AVITA Medical Inc. stock hit analyst price targetsRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Is it too late to sell AVITA Medical Inc.IPO Watch & Safe Capital Growth Trade Ideas - newser.com
How AVITA Medical Inc. stock performs in weak economyJuly 2025 Retail & Weekly Momentum Picks - newser.com
Will AVITA Medical Inc. stock outperform Nasdaq index2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is AVITA Medical Inc. stock a buy for dividend growth2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages AVITA Medical, Inc. (RCEL) Investors to Inquire about Securities Investigation - ACCESS Newswire
How risky is AVITA Medical Inc. stock now2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
What analysts say about AVITA Medical Inc stockEarnings Volatility Patterns & High Return Portfolio Growth - earlytimes.in
AVITA Medical to Announce Third Quarter 2025 Financial Results - Investing News Network
AVITA Medical (NASDAQ: RCEL) sets Nov. 6, 2025 call to discuss third-quarter results - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Investors to Reach Out - ACCESS Newswire
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL - The AI Journal
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation - FinancialContent
Avita Medical (RCEL) Gains Support for Recell in Australia - GuruFocus
AVITA Medical Welcomes Support for RECELL® in Burns in Australia - Investing News Network
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):